Lupus affects 1.5 million Americans, causing chronic pain, fatigue, and organ damage. Noah Oakland, a student at Virginia Tech, is researching new treatments for lupus using DNA-like molecules to ease symptoms. Oakland received an NIH F30 award to support his research, focusing on CpG ODNs to attenuate lupus in cell cultures, with plans to test in mouse models. The goal is to develop less invasive treatments leveraging the body’s natural immune responses. Oakland aims to pursue a career as a physician-scientist, treating patients in the clinic and conducting laboratory research. His work represents a novel approach to managing autoimmune diseases like lupus.
Source link
NIH funding supports innovative lupus research using DNA mimic molecules
